查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1572041

Antipilin 市场：按产品类型、应用、最终用户、分销管道、年龄层、治疗层级- 2025-2030 年全球预测

Antipyrine Market by Product Type (Capsules, Injectable, Liquid), Application (Anti-Inflammatory, Arthritis, Cold and Flu), End User, Distribution Channel, Age Group, Therapeutic Class - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年Antipilin市值为3.6322亿美元，预计2024年将达3.8299亿美元，复合年增长率为4.34%，到2030年将达到4.8929亿美元。

安替比林是主要用作镇痛剂和解热剂的药物化合物，在医学领域具有多种用途。对抗毛虫素的需求源自于其缓解疼痛和退烧的能力，使其成为多种非处方药和处方药配方中的重要成分。最终用途范围主要包括配製为滴耳剂以缓解耳痛和发炎，以及由于其药物动力学特性而在诊断应用中的潜在用途。根据市场洞察，抗毛虫素的成长受到耳部感染疾病盛行率的增加、对有效疼痛管理解决方案的需求不断增长以及药物输送系统的进步等因素的影响。安替比林的潜力在于探索其在新药物组合和配方中的作用，以满足不断增长的消费者群体寻求更全面的止痛选择的需求。这包括利用奈米技术的新研究来提高基于安替比林的药物的生物有效性和功效，特别是作为标靶治疗。然而，市场面临着严格的法律规范、长期使用的潜在副作用以及来自替代疗法的竞争等挑战，这些都限制了成长。为了抓住新的机会，公司必须专注于药物输送和个人化医疗的创新，以满足特定族群的需求。与研究机构合作详细研究其机制并发现新的治疗适应症将带来突破并增加我们在市场上的影响力。此外，在服务不足的市场中建立策略伙伴关係和扩大地理覆盖范围可能会支持成长。市场竞争激烈，但未来性，行业参与者保持适应性和主动性，确保合规性并解决安全问题，同时探索创新应用并提高市场相关性。

主要市场统计
基准年[2023] 3.6322 亿美元
预计年份 [2024] 38299万美元
预测年份 [2030] 4.8929 亿美元
复合年增长率（%） 4.34%

市场动态：揭示快速发展的抗毛林市场的关键市场洞察

供需的动态交互作用正在改变抗毛虫素市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 扩大以发炎作用为重点的研究活动。
    • 抗皮林非处方药需求不断增长影响市场动态
    • 越来越关注抗毛虫药物联合治疗的开发，以获得更好的临床结果
    • 政府对抗毛虫非专利药开发的倡议和财政支持推动了市场成长
  • 市场限制因素
    • 加强对抗毛虫药物潜在副作用和安全问题的审查和公众意识，影响消费者信心和销售；
    • 生产反皮林所需的优质原料的采购和稳定供应面临挑战。
  • 市场机会
    • 由于医疗保健投资增加，对抗皮林药物製剂的需求增加
    • 由于宠物拥有率上升，抗毛菌素在动物用药品中的使用扩大
    • 由于人口老化，疼痛管理解决方案对安替比林的需求不断增长
  • 市场挑战
    • 应对抗毛虫素产业供应链中断及原物料价格波动
    • 介绍抗毛虫生产流程中最尖端科技进步与创新

波特的五力：驾驭安匹林市场的策略工具

波特的五力框架是了解 Antipilin 市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解 Antipilin 市场的外部影响

外部宏观环境因素对塑造抗皮林市场的绩效动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解抗匹林市场竞争状况

Antipilin 市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵 Antipilin 市场供应商的绩效评估

FPNV定位矩阵是评估安替匹林市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了抗皮林市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对 Antipilin 市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 扩大抗发炎菌素抗发炎特性的研究力度
      • 非处方药需求的成长影响市场动态
      • 专注于开发安替比林联合治疗，以获得更好的临床效果
      • 政府对学名药开发的措施和资金推动市场成长
    • 抑制因素
      • 对与安替比林相关的潜在副作用和安全问题的审查和公众意识的加强影响了消费者的信心和销售。
      • 采购製造安替比林所需的优质原料并确保稳定供应是一项挑战，可能会影响生产效率。
    • 机会
      • 医疗保健投资的增加增加了对药物製剂中安替比林的需求
      • 宠物饲养量的增加扩大了抗毛虫素在动物医药上的应用
      • 人口老化趋势增加了疼痛管理解决方案中对安比林的需求
    • 任务
      • 管理抗毛虫产业的供应链中断和原物料价格波动
      • 将最先进的技术进步和创新引入安替比林生产工艺
  • 市场区隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章安替比林市场：依产品类型

  • 胶囊
  • 可注射的
  • 液体
  • 粉末
  • 药片

第七章安替比林市场：依应用分类

  • 发炎（药
  • 关节炎
  • 感冒和流感
  • 退烧
  • 缓解疼痛

第八章安替比林市场：依最终用户分类

  • 诊所
  • 居家护理
  • 医院
  • 调查机构

第九章安替比林市场：依通路分类

  • 药局
  • 医院药房
  • 网路药房
  • 零售药房

第 10 章 Antipilin 市场：依年龄组

  • 成人
  • 老年医学
  • 小儿科

第十一章依治疗层级分類的安替比林市场

  • 止痛药
  • 退烧剂
  • NSAIDs

第十二章 美洲反皮林市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十三章亚太抗毛素市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十四章 欧洲、中东及非洲抗毛林市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-1A1A064C0034

The Antipyrine Market was valued at USD 363.22 million in 2023, expected to reach USD 382.99 million in 2024, and is projected to grow at a CAGR of 4.34%, to USD 489.29 million by 2030.

Antipyrine, a pharmaceutical compound primarily used as an analgesic and antipyretic, has found various applications in the medical field. The necessity for antipyrine arises from its efficacy in alleviating pain and reducing fever, making it an essential component in the formulation of several over-the-counter and prescription medications. The end-use scope primarily includes its incorporation in ear drop solutions to relieve ear pain and inflammation and its potential use in diagnostic applications due to its pharmacokinetic properties. Market insights indicate that the growth of antipyrine is influenced by factors such as increased prevalence of ear infections, rising demand for effective pain management solutions, and advancements in drug delivery systems. A potential opportunity lies in the exploration of antipyrine's role in novel drug combinations and formulations, catering to an expanding consumer base seeking more comprehensive pain relief options. This includes leveraging emerging research in nanotechnology to enhance the bioavailability and efficacy of antipyrine-based medications, particularly for targeted therapies. However, the market faces challenges such as stringent regulatory frameworks, potential side effects associated with prolonged use, and competition from alternative therapies, which can impede growth. To capture emerging opportunities, businesses should focus on innovations in drug delivery and personalized medicine, catering to specific demographic needs. Collaborating with research institutions for in-depth studies on antipyrine's mechanism and discovering new therapeutic indications can lead to breakthroughs, fortifying market presence. Additionally, expanding geographic reach through strategic partnerships in underserved markets could bolster growth. The market is competitive yet promising, urging industry players to remain adaptive and forward-thinking, ensuring compliance and addressing safety concerns while exploring innovative applications to sustain market relevance and leadership.

KEY MARKET STATISTICS
Base Year [2023] USD 363.22 million
Estimated Year [2024] USD 382.99 million
Forecast Year [2030] USD 489.29 million
CAGR (%) 4.34%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Antipyrine Market

The Antipyrine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Expansion of research activities focusing on the anti-inflammatory properties of antipyrine
    • Escalating demand for over-the-counter antipyrine medications influencing market dynamics
    • Enhanced focus on developing combination therapies featuring antipyrine for better clinical outcomes
    • Government initiatives and funding for the development of generic antipyrine medications boosting market growth
  • Market Restraints
    • The increasing scrutiny and public awareness of the potential side effects and safety concerns associated with antipyrine, impacting consumer trust and sales
    • The challenges in sourcing and ensuring the consistent supply of high-quality raw materials required for manufacturing antipyrine, which can affect production efficiency
  • Market Opportunities
    • Increased demand for antipyrine in pharmaceutical formulations driven by rising healthcare investments
    • Expansion of antipyrine applications in veterinary medicines due to rising pet adoption rates
    • Growing need for antipyrine in pain management solutions spurred by aging population trends
  • Market Challenges
    • Managing supply chain disruptions and raw material price volatility in the antipyrine industry
    • Implementing cutting-edge technological advancements and innovation in the antipyrine production process

Porter's Five Forces: A Strategic Tool for Navigating the Antipyrine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Antipyrine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Antipyrine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Antipyrine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Antipyrine Market

A detailed market share analysis in the Antipyrine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Antipyrine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Antipyrine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Antipyrine Market

A strategic analysis of the Antipyrine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Antipyrine Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Amgen, AstraZeneca, Bayer, Bristol-Myers Squibb, Eli Lilly and Company, Gilead Sciences, GlaxoSmithKline, Hoffmann-La Roche, Johnson & Johnson, Merck & Co., Novartis, Novo Nordisk, Pfizer, Roche, Sanofi, Shionogi, Sun Pharmaceutical, Takeda Pharmaceutical Company, and Teva Pharmaceutical Industries.

Market Segmentation & Coverage

This research report categorizes the Antipyrine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Capsules, Injectable, Liquid, Powder, and Tablets.
  • Based on Application, market is studied across Anti-Inflammatory, Arthritis, Cold and Flu, Fever Reduction, and Pain Relief.
  • Based on End User, market is studied across Clinics, Homecare, Hospitals, and Research Institutes.
  • Based on Distribution Channel, market is studied across Drug Stores, Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Age Group, market is studied across Adults, Geriatrics, and Pediatrics.
  • Based on Therapeutic Class, market is studied across Analgesics, Antipyretics, and NSAIDs.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Expansion of research activities focusing on the anti-inflammatory properties of antipyrine
      • 5.1.1.2. Escalating demand for over-the-counter antipyrine medications influencing market dynamics
      • 5.1.1.3. Enhanced focus on developing combination therapies featuring antipyrine for better clinical outcomes
      • 5.1.1.4. Government initiatives and funding for the development of generic antipyrine medications boosting market growth
    • 5.1.2. Restraints
      • 5.1.2.1. The increasing scrutiny and public awareness of the potential side effects and safety concerns associated with antipyrine, impacting consumer trust and sales
      • 5.1.2.2. The challenges in sourcing and ensuring the consistent supply of high-quality raw materials required for manufacturing antipyrine, which can affect production efficiency
    • 5.1.3. Opportunities
      • 5.1.3.1. Increased demand for antipyrine in pharmaceutical formulations driven by rising healthcare investments
      • 5.1.3.2. Expansion of antipyrine applications in veterinary medicines due to rising pet adoption rates
      • 5.1.3.3. Growing need for antipyrine in pain management solutions spurred by aging population trends
    • 5.1.4. Challenges
      • 5.1.4.1. Managing supply chain disruptions and raw material price volatility in the antipyrine industry
      • 5.1.4.2. Implementing cutting-edge technological advancements and innovation in the antipyrine production process
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Antipyrine Market, by Product Type

  • 6.1. Introduction
  • 6.2. Capsules
  • 6.3. Injectable
  • 6.4. Liquid
  • 6.5. Powder
  • 6.6. Tablets

7. Antipyrine Market, by Application

  • 7.1. Introduction
  • 7.2. Anti-Inflammatory
  • 7.3. Arthritis
  • 7.4. Cold and Flu
  • 7.5. Fever Reduction
  • 7.6. Pain Relief

8. Antipyrine Market, by End User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Homecare
  • 8.4. Hospitals
  • 8.5. Research Institutes

9. Antipyrine Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Drug Stores
  • 9.3. Hospital Pharmacies
  • 9.4. Online Pharmacies
  • 9.5. Retail Pharmacies

10. Antipyrine Market, by Age Group

  • 10.1. Introduction
  • 10.2. Adults
  • 10.3. Geriatrics
  • 10.4. Pediatrics

11. Antipyrine Market, by Therapeutic Class

  • 11.1. Introduction
  • 11.2. Analgesics
  • 11.3. Antipyretics
  • 11.4. NSAIDs

12. Americas Antipyrine Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Antipyrine Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Antipyrine Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie
  • 2. Amgen
  • 3. AstraZeneca
  • 4. Bayer
  • 5. Bristol-Myers Squibb
  • 6. Eli Lilly and Company
  • 7. Gilead Sciences
  • 8. GlaxoSmithKline
  • 9. Hoffmann-La Roche
  • 10. Johnson & Johnson
  • 11. Merck & Co.
  • 12. Novartis
  • 13. Novo Nordisk
  • 14. Pfizer
  • 15. Roche
  • 16. Sanofi
  • 17. Shionogi
  • 18. Sun Pharmaceutical
  • 19. Takeda Pharmaceutical Company
  • 20. Teva Pharmaceutical Industries

LIST OF FIGURES

  • FIGURE 1. ANTIPYRINE MARKET RESEARCH PROCESS
  • FIGURE 2. ANTIPYRINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANTIPYRINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANTIPYRINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANTIPYRINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANTIPYRINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANTIPYRINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ANTIPYRINE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ANTIPYRINE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS ANTIPYRINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS ANTIPYRINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES ANTIPYRINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES ANTIPYRINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. ANTIPYRINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. ANTIPYRINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANTIPYRINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANTIPYRINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTIPYRINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANTIPYRINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANTIPYRINE MARKET DYNAMICS
  • TABLE 7. GLOBAL ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANTIPYRINE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANTIPYRINE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANTIPYRINE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANTIPYRINE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANTIPYRINE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANTIPYRINE MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANTIPYRINE MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANTIPYRINE MARKET SIZE, BY COLD AND FLU, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANTIPYRINE MARKET SIZE, BY FEVER REDUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ANTIPYRINE MARKET SIZE, BY PAIN RELIEF, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ANTIPYRINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANTIPYRINE MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ANTIPYRINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ANTIPYRINE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ANTIPYRINE MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ANTIPYRINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ANTIPYRINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ANTIPYRINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ANTIPYRINE MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ANTIPYRINE MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ANTIPYRINE MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL ANTIPYRINE MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL ANTIPYRINE MARKET SIZE, BY ANTIPYRETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL ANTIPYRINE MARKET SIZE, BY NSAIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS ANTIPYRINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES ANTIPYRINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. PHILIPPINES ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. SINGAPORE ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 129. SINGAPORE ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH KOREA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. TAIWAN ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 141. TAIWAN ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. THAILAND ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 147. THAILAND ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. VIETNAM ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 153. VIETNAM ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 165. DENMARK ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 166. DENMARK ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. EGYPT ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 172. EGYPT ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 177. FINLAND ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 178. FINLAND ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. FRANCE ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 184. FRANCE ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 189. GERMANY ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 190. GERMANY ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 195. ISRAEL ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 196. ISRAEL ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 200. ITALY ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 201. ITALY ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 202. ITALY ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 208. NETHERLANDS ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 213. NIGERIA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 214. NIGERIA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 219. NORWAY ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 220. NORWAY ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 224. POLAND ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 225. POLAND ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 226. POLAND ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. QATAR ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 231. QATAR ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 232. QATAR ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 237. RUSSIA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 238. RUSSIA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 244. SAUDI ARABIA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH AFRICA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 255. SPAIN ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 256. SPAIN ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 261. SWEDEN ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 262. SWEDEN ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 266. SWITZERLAND ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 268. SWITZERLAND ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 272. TURKEY ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 273. TURKEY ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 274. TURKEY ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED KINGDOM ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 286. UNITED KINGDOM ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 287. ANTIPYRINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 288. ANTIPYRINE MARKET, FPNV POSITIONING MATRIX, 2023